OrbiMed’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-233,100
Closed -$22.3M 121
2019
Q1
$22.3M Buy
+233,100
New +$22.3M 0.34% 68
2016
Q2
Sell
-249,400
Closed -$7.33M 136
2016
Q1
$7.33M Sell
249,400
-254,900
-51% -$7.49M 0.08% 102
2015
Q4
$16.7M Buy
+504,300
New +$16.7M 0.15% 74